Journal
KIDNEY INTERNATIONAL
Volume 82, Issue 2, Pages 138-146Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2012.68
Keywords
dedifferentiation; directed differentiation; induced pluripotency; nephron progenitor; reprogramming; transdifferentiation
Categories
Funding
- Rosamond Siemon Postgraduate Scholarship
- National Institutes of Digestion Diabetes and Kidney, NIH [DK070136]
- NHMRC [ID631362]
- Australian Stem Cell Centre
Ask authors/readers for more resources
Nuclear reprogramming has reshaped stem cell science and created new avenues for cell-based therapies. The ability to bestow any given phenotype upon adult cells regardless of their origin is an exciting possibility. How can this powerful tool be harnessed for the treatment of kidney disease? Many approaches, including induced pluripotent stem cell (iPSC) production, direct lineage conversion, and reprogramming to a kidney progenitor, are now possible. Indeed, the generation of iPSC lines from adult kidney-derived cells has been successfully achieved. This, however, is just the beginning of the challenge. This review will discuss the fundamental concepts of transcription factor-based reprogramming in its various forms, highlighting recent advances in the field and how these are applicable to the kidney. The relative merits of each approach will be discussed in the context of what is a realistic and feasible strategy for kidney regeneration via reprogramming. Kidney International (2012) 82, 138-146; doi: 10.1038/ki.2012.68; published online 21 March 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available